Skip Nav Destination
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
Treatment of NLPHL
Issue Archive
December 19 2013
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPER
REVIEW ARTICLE
Smoldering multiple myeloma requiring treatment: time for a new definition?
Angela Dispenzieri,A. Keith Stewart,Asher Chanan-Khan,S. Vincent Rajkumar,Robert A. Kyle,Rafael Fonseca,Prashant Kapoor,P. Leif Bergsagel,Arleigh McCurdy,Morie A. Gertz,Martha Q. Lacy,John A. Lust,Stephen J. Russell,Steven R. Zeldenrust,Craig Reeder,Vivek Roy,Francis Buadi,David Dingli,Suzanne R. Hayman,Nelson Leung,Yi Lin,Joseph Mikhael,Shaji K. Kumar
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
Clinical Trials & Observations
Mark N. Polizzotto,Thomas S. Uldrick,Victoria Wang,Karen Aleman,Kathleen M. Wyvill,Vickie Marshall,Stefania Pittaluga,Deirdre O’Mahony,Denise Whitby,Giovanna Tosato,Seth M. Steinberg,Richard F. Little,Robert Yarchoan
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture
Génève Awong,Jastaranpreet Singh,Mahmood Mohtashami,Maria Malm,Ross N. La Motte-Mohs,Patricia M. Benveniste,Pablo Serra,Elaine Herer,Marcel R. van den Brink,Juan Carlos Zúñiga-Pflücker
LYMPHOID NEOPLASIA
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
CME
Sylvia Hartmann,Dennis A. Eichenauer,Annette Plütschow,Anja Mottok,Roshanak Bob,Karoline Koch,Heinz-Wolfram Bernd,Sergio Cogliatti,Michael Hummel,Alfred C. Feller,German Ott,Peter Möller,Andreas Rosenwald,Harald Stein,Martin-Leo Hansmann,Andreas Engert,Wolfram Klapper
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia
Gillian G. Johnson,Ke Lin,Trevor F. Cox,Melanie Oates,David R. Sibson,Richard Eccles,Bryony Lloyd,Laura-Jayne Gardiner,Daniel F. Carr,Munir Pirmohamed,Jonathan C. Strefford,David G. Oscier,David Gonzalez de Castro,Monica Else,Daniel Catovsky,Andrew R. Pettitt
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience
Régis Peffault de Latour,Raphael Porcher,Jean-Hugues Dalle,Mahmoud Aljurf,Elisabeth T. Korthof,Johanna Svahn,Roelof Willemze,Cristina Barrenetxea,Valerie Mialou,Jean Soulier,Mouhab Ayas,Rosi Oneto,Andrea Bacigalupo,Judith C. W. Marsh,Christina Peters,Gerard Socie,Carlo Dufour,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation,on behalf of the FA Committee of the Severe Aplastic Anemia Working Party and the Pediatric Working Party of the European Group for Blood and Marrow Transplantation
CORRESPONDENCE
Treatment of NLPHL
Clinical Trials & Observations
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
![issue cover]()
The anti-C2 domain immune response to factor VIII. The X-ray crystal structure of factor VIII is represented by electrostatic surface potential, and three different inhibitory antibodies are represented as ribbon diagrams (cyan: 3E6 classical antibody, green: G99 non-classical antibody, orange: BO2C11 classical antibody). Each inhibitory antibody recognizes discrete regions of the factor VIII C2 domain, predominantly through electrostatic interactions (blue surface: positive charge, red surface: negative charge). See the article by Walter et al on page 4270.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
